Selective neuromicrovascular endothelial cell death by 8-iso-prostaglandin F2α: Possible role in ischemic brain injury

Stroke

Volumn 34, Issue 3, 2003, Pages 776-782

  Brault, Sonia ^a,b   Martinez Bermudez, Ana Katherine ^a,b   Marrache, Anne Marilise ^a,b   Gobeil Jr , Fernand ^a   Hou, Xin ^a   Beauchamp, Martin ^a   Quiniou, Christiane ^a   Almazan, Guillermina ^b   Lachance, Christian ^a   Roberts II, Jackson ^c   Varma, Daya R ^b   Chemtob, Sylvain ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Brain damage; Necrosis; Oxidants; Thromboxanes; White matter

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 METHYL 2 (3 PYRIDYL) 1 INDOLEOCTANOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; FUREGRELATE; LACTATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; LIPID PEROXIDATION; MACROGLIA; MICROVASCULATURE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WHITE MATTER;

ANIMALS; ASTROCYTES; BRAIN; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; DINOPROST; DINOPROSTONE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; F2-ISOPROSTANES; INJECTIONS, INTRAVENTRICULAR; ISOPROSTANES; L-LACTATE DEHYDROGENASE; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; SWINE; THROMBOXANE A2; THROMBOXANE-A SYNTHASE;

EID: 0037335984     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000055763.76479.E6     Document Type: Article

References (32)

1. Noseworthy MD, Bray TM. Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic Biol Med. 1998;24:942-951.
2. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol. 1998;5:135-151.
3. Nishigaya K, Yoshida Y, Sasuga M, Nukui H, Ooneda G. Effect of recirculation on exacerbation of ischemic vascular lesions in rat brain. Stroke. 1991;22:635-642.
4. Pesonen E, Kaprio E, Rapola J, Soveri T, Oksanen H. Endothelial cell damage in piglet coronary artery after intravenous administration of E. coli endotoxin: a scanning and transmission electron-microscopic study. Atherosclerosis. 1981;40:65-73.
5. D'Amore PA, Sweet E. Effects of hyperoxia on microvascular cells in vitro. In Vitro Cell Dev Biol. 1987;23:123-128.
6. Auge N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J. 1995;309(pt 3):1015-1020.
7. Halks-Miller M, Henderson M, Eng LF. Alpha tocopherol decreases lipid peroxidation, neuronal necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain. J Neuropathol Exp Neurol. 1986;45:471-484.
8. Kondo T, Kinouchi H, Kawase M, Yoshimoto T. Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neurosci Lett. 1996;215:103-106.
9. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A. 1990;87:9383-9387.
10. 2α, is formed in vivo. Biochim Biophys Acta. 1994;1210:244-248.
11. 2α in isolated perfused rat lung. J Appl Physiol. 1993;74:460-465.
12. Lahaie I, Hardy P, Hou X, Hassessian H, Asselin P, Lachapelle P, Almazan G, Varma DR, Morrow JD, Roberts LJ, Chemtob S. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol. 1998;274:R1406-R1416.
13. Hou X, Gobeil F, Peri K Jr, Speranza G, Marrache AM, Lachapelle P, Roberts J, Varma DR, Chemtob S. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels. Stroke. 2000;31:516-524.
14. Patrignani P, Santini G, Panara MR, Sciulli MG, Greco A, Rotondo MT, di Giamberardino M, Maclouf J, Ciabattoni G, Patrono C. Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation. Br J Pharmacol. 1996;118:1285-1293.
15. Hart CM, Karman RJ, Blackburn TL, Gupta MP, Garcia JG, Mohler ER III. Role of 8-epi PGF2alpha, 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier function. Prostaglandins. Leukot Essent Fatty Acids. 1998;58:9-16.
16. Natarajan V. Oxidants and signal transduction in vascular endothelium. J Lab Clin Med. 1995;125:26-37.
17. Marliere S, Cracowski JL, Durand T, Chavanon O, Bessard J, Guy A, Stanke-Labesque F, Rossi JC, Bessard G. The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein. Br J Pharmacol. 2002;135:1276-1280.
18. Beauchamp MH, Martinez-Bermudez AK, Gobeil F Jr, Marrache AM, Hou X, Speranza G, Abran D, Quiniou C, Lachapelle P, Roberts J, Almazan G, Varma DR, Chemtob S. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy. J Appl Physiol. 2001;90:2279-2288.
19. Watters GV, Cutler RW. Cerebrospinal fluid formation and reabsorption in children. Neurology. 1968;18:296.
20. Burlacu A, Jinga V, Gafencu AV, Simionescu M. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell Tissue Res. 2001;306:409-416.
21. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855-1859.
22. Gardner AM, Xu FH, Fady C, Jacoby FJ, Duffey DC, Tu Y, Lichtenstein A. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic Biol Med. 1997;22:73-83.
23. Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol. 2000;131:441-446.
24. Simm A, Bertsch G, Frank H, Zimmermann U, Hoppe J. Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis. J Cell Sci. 1997;110(pt 7):819-828.
25. Fitzgerald GA, Healy C, Daugherty J. Thromboxane A2 biosynthesis in human disease. Fed Proc. 1987;46:154-158.
26. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219-228.
27. Nakahata N, Ishimoto H, Kurita M, Ohmori K, Takahashi A, Nakanishi H. The presence of thromboxane A2 receptors in cultured astrocytes from rabbit brain. Brain Res. 1992;583:100-104.
28. Sachinidis A, Flesch M, Ko Y, Schror K, Bohm M, Dusing R, Vetter H. Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension. 1995;26:771-780.
29. Fukunaga M, Makita N, Roberts LJ, Morrow JD, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264:C1619-C1624.
30. Hardy P, Dumont I, Bhattacharya M, Hou X, Lachapelle P, Varma DR, Chemtob S. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res. 2000;47:489-509.
31. Oranje WA, Rondas-Colbers GJ, Swennen GN, Wolffenbuttel BH. Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease? Neth J Med. 1998;53:61-68.
32. Sattar N, Petrie JR, Jaap AJ. The atherogenic lipoprotein phenotype and vascular endothelial dysfunction. Atherosclerosis. 1998;138:229-235.